Chunxia Chen

8.7k citations
188 papers · 5.3k · 2 hit papers · h-index 35

Impact in

  • Immunology top 2%
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
    • Immunotherapy and Immune Responses
  • Hepatology top 2%

Papers in

    • RNA Research and Splicing 7
    • Immune Cell Function and Interaction 16
    • T-cell and B-cell Immunology 11
    • Immunotherapy and Immune Responses 5
    • Immune Response and Inflammation 5

Chunxia Chen

175 papers receiving 5.2k citations

Chunxia Chen's Hit Papers

Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial 2020 · 433 citations
4330+6+12Years since publication250500750

Peers

Chunxia Chen
Comparison fields: 5 of 158
  • Immunology 1.3k
  • Hepatology 284
  • Oncology 828
  • Cancer Research 421
  • Molecular Biology 2.0k
Replace Yutaka Kawahito with:
Yutaka Kawahito Japan
Hai Huang China
Bob van de Water Netherlands
Shu Zhang China
Takeshi Nagashima Japan
Weiping Chen China
Jaye Chin‐Dusting Australia
Margery A. Connelly United States
Ruth Roberts United Kingdom
Teake Kooistra Netherlands
Chunxia Chen relative to Yutaka Kawahito Japan Yutaka Kawahito's profile →
Citations per field
00.5×1.5×2.4×
Yutaka Kawahito · 1×
Citations per year

Countries citing papers authored by Chunxia Chen

Since Specialization
Citations

This map shows the geographic impact of Chunxia Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunxia Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunxia Chen more than expected).

Fields of papers citing papers by Chunxia Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunxia Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunxia Chen. The network helps show where Chunxia Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Chunxia Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chunxia Chen Line = papers co-authored together Chunxia Chen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 188 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Deacetylase inhibition promotes the generation and function of regulatory T cells
Hit paper breakdown →
2007785
2
Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial
Hit paper breakdown →
2020433
3 2000432
4 2006188
5 2000178
6 1997168
7 2020102
8 2020101
9 201097
10 201389
11 201283
12 201780
13 200774
14 201266
15 201663
16 201155
17 201655
18 200953
19 201250
20 201947

About Chunxia Chen

Chunxia Chen is a scholar working on Molecular Biology, Immunology, Surgery, Oncology and Epidemiology, having authored 188 papers that have together received 5.3k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (16 papers), T-cell and B-cell Immunology (11 papers), Radiomics and Machine Learning in Medical Imaging (8 papers), RNA Research and Splicing (7 papers), Autophagy in Disease and Therapy (6 papers), Breast Cancer Treatment Studies (6 papers), Immunotherapy and Immune Responses (5 papers) and Immune Response and Inflammation (5 papers). The work is most often cited by research in Immunology (1.3k citations), Hepatology (284 citations), Oncology (828 citations), Cancer Research (421 citations) and Molecular Biology (2.0k citations). Chunxia Chen has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Andrew D. Wells, Kazuko Nishikura, Wayne W. Hancock, Fang Lai, Kenneth C. Carter, Qingde Wang, Liqing Wang, Edwin F. de Zoeten, Mark I. Greene and Engin Özkaynak. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE, The Journal of Immunology, Journal of Biological Chemistry and Journal for ImmunoTherapy of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact